Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention

European Heart Journal: Acute Cardiovascular Care

Volumn 3, Issue 1, 2014, Pages 84-92

  Rohla, Miklos ^a   Freynhofer, Matthias K ^a   Tentzeris, Ioannis ^a   Farhan, Serdar ^a   Wojta, Johann ^b   Huber, Kurt ^a   Weiss, Thomas W ^a  

^a WILHELMINEN HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute coronary syndrome; osmolality; risk stratification

Indexed keywords

ACUTE CORONARY SYNDROME; AUSTRIA; BLOOD; EPIDEMIOLOGY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MORTALITY; OSMOLARITY; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TIME; TRENDS;

ACUTE CORONARY SYNDROME; AUSTRIA; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TIME FACTORS;

EID: 84925222546     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872613516018     Document Type: Article

References (32)

1. Al Suwaidi J, Reddan DN, Williams K, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002; 106: 974–980.
2. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342–1349.
3. Bellodi G, Manicardi V, Malavasi V, et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989; 64: 885–888.
4. Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000; 101: 2557–67.
5. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773–778.
6. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014–1021.
7. Kirtane AJ, Leder, Waikar SS, et al. Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. J Am Coll Cardiol 2005; 45: 1781–1786.
8. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005; 111: 3078–3086.
9. Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 1995; 91: 1659–1668.
10. Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355: 1126–1130.
11. Bhalla V, Willis S, Maisel AS. B-type natriuretic peptide: the level and the drug–partners in the diagnosis of congestive heart failure. Congest Heart Fail 2004; 10: 3–27.
12. Galvani M, Ferrini D, Ottani F. Natriuretic peptides for risk stratification of patients with acute coronary syndromes. Eur J Heart Fail 2004; 6: 327–333.
13. Gibson CM, Pinto DS, Murphy SA, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 2003; 42: 1535–1543.
14. Dorwart WV, Chalmers L. Comparison of methods for calculating serum osmolality form chemical concentrations, and the prognostic value of such calculations. Clin Chem 1975; 21: 190–194.
15. Hall JE, Guyton AC. Guyton and Hall textbook of medical physiology, 12th ed. Philadelphia, PA: Saunders/Elsevier, 2011.
16. Hoffman RS, Smilkstein MJ, Howland MA, et al. Osmol gaps revisited: normal values and limitations. J Toxicol Clin Toxicol 1993; 31: 81–93.
17. Falck G, Schjott J, Jynge P. Hyperosmotic pretreatment reduces infarct size in the rat heart. Physiol Res 1999; 48: 331–340.
18. Powell WJ Jr, DiBona DR, Flores J, et al. The protective effect of hyperosmotic mannitol in myocardial ischemia and necrosis. Circulation 1976; 54: 603–615.
19. Magovern GJ Jr, Bolling SF, Casale AS, et al. The mechanism of mannitol in reducing ischemic injury: hyperosmolarity or hydroxyl scavenger? Circulation 1984; 70: I91–I95.
20. Bhalla A, Sankaralingam S, Dundas R, et al. Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke 2000; 31: 2043–2048.
21. Oliver MF. Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes. Am J Med 2002; 112: 305–311.
22. Cheung NW, Wong VW, McLean M. The Hyperglycemia:Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006; 29: 765–770.
23. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997; 314: 1512–1515.
24. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57–65.
25. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26: 650–661.
26. Masoudi FA, Plomondon ME, Magid DJ, et al. Renal insufficiency and mortality from acute coronary syndromes. Am Heart J 2004; 147: 623–629.
27. Conte G, Dal Canton A, Terribile M, et al. Renal handling of urea in subjects with persistent azotemia and normal renal function. Kidney Int 1987; 32: 721–727.
28. Usberti M, Federico S, Di Minno G, et al. Effects of angiotensin II on plasma ADH, prostaglandin synthesis, and water excretion in normal humans. Am J Physiol 1985; 248: F254–F259.
29. Aronson D, Mittleman MA, Burger AJ. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med 2004; 116: 466–473.
30. Dal Canton A, Fuiano G, Conte G, et al. Mechanism of increased plasma urea after diuretic therapy in uraemic patients. Clin Sci 1985; 68: 255–261.
31. Bengtson JR, Kaplan AJ, Pieper KS, et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol 1992; 20: 1482–1489.
32. Rector TS, Cohn JN. Prognosis in congestive heart failure. Annu Rev Med 1994; 45: 341–350.